Cargando…

Pneumonia severity scores in resource poor settings

Clinical prognostc scores are increasingly used to streamline care in well-resourced setngs. The potental benefts of identfying patents at risk of clinical deterioraton and poor outcome, delivering appropriate higher level clinical care, and increasing efciency are clear. In this focused review, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Rylance, Jamie, Waitt, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922327/
https://www.ncbi.nlm.nih.gov/pubmed/31641572
http://dx.doi.org/10.15172/pneu.2014.5/481
_version_ 1783318177096138752
author Rylance, Jamie
Waitt, Peter
author_facet Rylance, Jamie
Waitt, Peter
author_sort Rylance, Jamie
collection PubMed
description Clinical prognostc scores are increasingly used to streamline care in well-resourced setngs. The potental benefts of identfying patents at risk of clinical deterioraton and poor outcome, delivering appropriate higher level clinical care, and increasing efciency are clear. In this focused review, we examine the use and applicability of severity scores applied to patents with community acquired pneumonia in resource poor setngs. We challenge clinical researchers working in such systems to consider the generalisability of existng severity scores in their populatons, and where performance of scores is suboptmal, to promote eforts to develop and validate new tools for the beneft of patents and healthcare systems.
format Online
Article
Text
id pubmed-5922327
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59223272019-10-22 Pneumonia severity scores in resource poor settings Rylance, Jamie Waitt, Peter Pneumonia (Nathan) Review Clinical prognostc scores are increasingly used to streamline care in well-resourced setngs. The potental benefts of identfying patents at risk of clinical deterioraton and poor outcome, delivering appropriate higher level clinical care, and increasing efciency are clear. In this focused review, we examine the use and applicability of severity scores applied to patents with community acquired pneumonia in resource poor setngs. We challenge clinical researchers working in such systems to consider the generalisability of existng severity scores in their populatons, and where performance of scores is suboptmal, to promote eforts to develop and validate new tools for the beneft of patents and healthcare systems. BioMed Central 2014-12-01 /pmc/articles/PMC5922327/ /pubmed/31641572 http://dx.doi.org/10.15172/pneu.2014.5/481 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/3.0/Copyright: This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Rylance, Jamie
Waitt, Peter
Pneumonia severity scores in resource poor settings
title Pneumonia severity scores in resource poor settings
title_full Pneumonia severity scores in resource poor settings
title_fullStr Pneumonia severity scores in resource poor settings
title_full_unstemmed Pneumonia severity scores in resource poor settings
title_short Pneumonia severity scores in resource poor settings
title_sort pneumonia severity scores in resource poor settings
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922327/
https://www.ncbi.nlm.nih.gov/pubmed/31641572
http://dx.doi.org/10.15172/pneu.2014.5/481
work_keys_str_mv AT rylancejamie pneumoniaseverityscoresinresourcepoorsettings
AT waittpeter pneumoniaseverityscoresinresourcepoorsettings